市場調查報告書
商品編碼
1388224
潛在性結核診斷的全球市場:化驗,危險因素,實驗室/場所預測 - 附執行顧問指南(2024年~2028年)Latent TB Diagnostics Global Markets by Assay, by Risk Factor, and by Lab/Place. With Executive and Consultant Guides and Market Analysis and Forecasts 2024 - 2028 |
本報告提供全球潛在性結核診斷市場相關調查,提供市場概要,以及化驗,危險因素,實驗室/場所趨勢,及加入此市場的主要企業簡介等資訊。
Your report is provided on a 12-month subscription basis from the date you receive your first report. You will receive 2 or more updated versions of the complete report during the 12 months. At least one of these updates will provide forecasts based on next year's data.
Latent TB Diagnostics was the province of a few established companies producing a commodity product. No longer. New technologies. New niche markets.
TB Diagnostics is growing, and in some segments the growth is dramatic. Find out who the new leaders are and what areas are most lucrative. What are the basics of competition?
The report forecasts the market size out five years. Some players have already made their mark but disruptive diagnostic technology could change the playing field. Learn about this market including the issues and outlooks.
All report data is available in Excel format on request.
Make investment decisions and valuations with confidence using the latest data.
Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes: